Profiling antibodies to class II HLA in transplant patient sera

Curtis McMurtrey, Dave Lowe, Rico Buchli, Sunil Daga, Derek Royer, Alisha Humphrey, Steven Cate, Sean Osborn, Aleksandar Mojsilovic, Rodney VanGundy, Wilfried Bardet, Andrew Duty, Danijela Mojsilovic, Kenneth Jackson, Peter Stastny, David Briggs, Daniel Zehnder, Rob Higgins, William Hildebrand

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Immunizing events including pregnancy, transfusions, and transplantation promote strong alloantibody responses to HLA. Such alloantibodies to HLA preclude organ transplantation, foster hyperacute rejection, and contribute to chronic transplant failure. Diagnostic antibody-screening assays detect alloreactive antibodies, yet key attributes including antibody concentration and isotype remain largely unexplored. The goal here was to provide a detailed profile of allogeneic antibodies to class II HLA. Methodologically, alloantibodies were purified from sensitized patient sera using an HLA-DR11 immunoaffinity column and subsequently categorized. Antibodies to DR11 were found to fix complement, exist at a median serum concentration of 2.3. μg/mL, consist of all isotypes, and isotypes IgG2, IgM, and IgE were elevated. Because multimeric isotypes can confound diagnostic determinations of antibody concentration, IgM and IgA isotypes were removed and DR11-IgG tested alone. Despite removal of multimeric isotypes, patient-to-patient antibody concentrations did not correlate with MFI values. In conclusion, allogeneic antibody responses to DR11 are comprised of all antibody isotypes at differing proportions, these combined isotypes fix complement at nominal serum concentrations, and enhancements other than the removal of IgM and IgA multimeric isotypes may be required if MFI is to be used as a means of determining anti-HLA serum antibody concentrations in diagnostic clinical assays.

Original languageEnglish (US)
Pages (from-to)261-270
Number of pages10
JournalHuman Immunology
Volume75
Issue number3
DOIs
StatePublished - Mar 2014

Fingerprint

Immunoglobulin Isotypes
Transplants
Antibodies
Serum
Isoantibodies
Immunoglobulin M
Immunoglobulin A
Immunoglobulin G
Organ Transplantation
Immunoglobulin E
Antibody Formation
Transplantation
Pregnancy

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

McMurtrey, C., Lowe, D., Buchli, R., Daga, S., Royer, D., Humphrey, A., ... Hildebrand, W. (2014). Profiling antibodies to class II HLA in transplant patient sera. Human Immunology, 75(3), 261-270. https://doi.org/10.1016/j.humimm.2013.11.015

Profiling antibodies to class II HLA in transplant patient sera. / McMurtrey, Curtis; Lowe, Dave; Buchli, Rico; Daga, Sunil; Royer, Derek; Humphrey, Alisha; Cate, Steven; Osborn, Sean; Mojsilovic, Aleksandar; VanGundy, Rodney; Bardet, Wilfried; Duty, Andrew; Mojsilovic, Danijela; Jackson, Kenneth; Stastny, Peter; Briggs, David; Zehnder, Daniel; Higgins, Rob; Hildebrand, William.

In: Human Immunology, Vol. 75, No. 3, 03.2014, p. 261-270.

Research output: Contribution to journalArticle

McMurtrey, C, Lowe, D, Buchli, R, Daga, S, Royer, D, Humphrey, A, Cate, S, Osborn, S, Mojsilovic, A, VanGundy, R, Bardet, W, Duty, A, Mojsilovic, D, Jackson, K, Stastny, P, Briggs, D, Zehnder, D, Higgins, R & Hildebrand, W 2014, 'Profiling antibodies to class II HLA in transplant patient sera', Human Immunology, vol. 75, no. 3, pp. 261-270. https://doi.org/10.1016/j.humimm.2013.11.015
McMurtrey C, Lowe D, Buchli R, Daga S, Royer D, Humphrey A et al. Profiling antibodies to class II HLA in transplant patient sera. Human Immunology. 2014 Mar;75(3):261-270. https://doi.org/10.1016/j.humimm.2013.11.015
McMurtrey, Curtis ; Lowe, Dave ; Buchli, Rico ; Daga, Sunil ; Royer, Derek ; Humphrey, Alisha ; Cate, Steven ; Osborn, Sean ; Mojsilovic, Aleksandar ; VanGundy, Rodney ; Bardet, Wilfried ; Duty, Andrew ; Mojsilovic, Danijela ; Jackson, Kenneth ; Stastny, Peter ; Briggs, David ; Zehnder, Daniel ; Higgins, Rob ; Hildebrand, William. / Profiling antibodies to class II HLA in transplant patient sera. In: Human Immunology. 2014 ; Vol. 75, No. 3. pp. 261-270.
@article{d1b27a37d7df478692fb229fa632ffd6,
title = "Profiling antibodies to class II HLA in transplant patient sera",
abstract = "Immunizing events including pregnancy, transfusions, and transplantation promote strong alloantibody responses to HLA. Such alloantibodies to HLA preclude organ transplantation, foster hyperacute rejection, and contribute to chronic transplant failure. Diagnostic antibody-screening assays detect alloreactive antibodies, yet key attributes including antibody concentration and isotype remain largely unexplored. The goal here was to provide a detailed profile of allogeneic antibodies to class II HLA. Methodologically, alloantibodies were purified from sensitized patient sera using an HLA-DR11 immunoaffinity column and subsequently categorized. Antibodies to DR11 were found to fix complement, exist at a median serum concentration of 2.3. μg/mL, consist of all isotypes, and isotypes IgG2, IgM, and IgE were elevated. Because multimeric isotypes can confound diagnostic determinations of antibody concentration, IgM and IgA isotypes were removed and DR11-IgG tested alone. Despite removal of multimeric isotypes, patient-to-patient antibody concentrations did not correlate with MFI values. In conclusion, allogeneic antibody responses to DR11 are comprised of all antibody isotypes at differing proportions, these combined isotypes fix complement at nominal serum concentrations, and enhancements other than the removal of IgM and IgA multimeric isotypes may be required if MFI is to be used as a means of determining anti-HLA serum antibody concentrations in diagnostic clinical assays.",
author = "Curtis McMurtrey and Dave Lowe and Rico Buchli and Sunil Daga and Derek Royer and Alisha Humphrey and Steven Cate and Sean Osborn and Aleksandar Mojsilovic and Rodney VanGundy and Wilfried Bardet and Andrew Duty and Danijela Mojsilovic and Kenneth Jackson and Peter Stastny and David Briggs and Daniel Zehnder and Rob Higgins and William Hildebrand",
year = "2014",
month = "3",
doi = "10.1016/j.humimm.2013.11.015",
language = "English (US)",
volume = "75",
pages = "261--270",
journal = "Human Immunology",
issn = "0198-8859",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Profiling antibodies to class II HLA in transplant patient sera

AU - McMurtrey, Curtis

AU - Lowe, Dave

AU - Buchli, Rico

AU - Daga, Sunil

AU - Royer, Derek

AU - Humphrey, Alisha

AU - Cate, Steven

AU - Osborn, Sean

AU - Mojsilovic, Aleksandar

AU - VanGundy, Rodney

AU - Bardet, Wilfried

AU - Duty, Andrew

AU - Mojsilovic, Danijela

AU - Jackson, Kenneth

AU - Stastny, Peter

AU - Briggs, David

AU - Zehnder, Daniel

AU - Higgins, Rob

AU - Hildebrand, William

PY - 2014/3

Y1 - 2014/3

N2 - Immunizing events including pregnancy, transfusions, and transplantation promote strong alloantibody responses to HLA. Such alloantibodies to HLA preclude organ transplantation, foster hyperacute rejection, and contribute to chronic transplant failure. Diagnostic antibody-screening assays detect alloreactive antibodies, yet key attributes including antibody concentration and isotype remain largely unexplored. The goal here was to provide a detailed profile of allogeneic antibodies to class II HLA. Methodologically, alloantibodies were purified from sensitized patient sera using an HLA-DR11 immunoaffinity column and subsequently categorized. Antibodies to DR11 were found to fix complement, exist at a median serum concentration of 2.3. μg/mL, consist of all isotypes, and isotypes IgG2, IgM, and IgE were elevated. Because multimeric isotypes can confound diagnostic determinations of antibody concentration, IgM and IgA isotypes were removed and DR11-IgG tested alone. Despite removal of multimeric isotypes, patient-to-patient antibody concentrations did not correlate with MFI values. In conclusion, allogeneic antibody responses to DR11 are comprised of all antibody isotypes at differing proportions, these combined isotypes fix complement at nominal serum concentrations, and enhancements other than the removal of IgM and IgA multimeric isotypes may be required if MFI is to be used as a means of determining anti-HLA serum antibody concentrations in diagnostic clinical assays.

AB - Immunizing events including pregnancy, transfusions, and transplantation promote strong alloantibody responses to HLA. Such alloantibodies to HLA preclude organ transplantation, foster hyperacute rejection, and contribute to chronic transplant failure. Diagnostic antibody-screening assays detect alloreactive antibodies, yet key attributes including antibody concentration and isotype remain largely unexplored. The goal here was to provide a detailed profile of allogeneic antibodies to class II HLA. Methodologically, alloantibodies were purified from sensitized patient sera using an HLA-DR11 immunoaffinity column and subsequently categorized. Antibodies to DR11 were found to fix complement, exist at a median serum concentration of 2.3. μg/mL, consist of all isotypes, and isotypes IgG2, IgM, and IgE were elevated. Because multimeric isotypes can confound diagnostic determinations of antibody concentration, IgM and IgA isotypes were removed and DR11-IgG tested alone. Despite removal of multimeric isotypes, patient-to-patient antibody concentrations did not correlate with MFI values. In conclusion, allogeneic antibody responses to DR11 are comprised of all antibody isotypes at differing proportions, these combined isotypes fix complement at nominal serum concentrations, and enhancements other than the removal of IgM and IgA multimeric isotypes may be required if MFI is to be used as a means of determining anti-HLA serum antibody concentrations in diagnostic clinical assays.

UR - http://www.scopus.com/inward/record.url?scp=84893800075&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893800075&partnerID=8YFLogxK

U2 - 10.1016/j.humimm.2013.11.015

DO - 10.1016/j.humimm.2013.11.015

M3 - Article

C2 - 24269696

AN - SCOPUS:84893800075

VL - 75

SP - 261

EP - 270

JO - Human Immunology

JF - Human Immunology

SN - 0198-8859

IS - 3

ER -